Wilbanks Smith & Thomas Asset Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.06M | Hold |
2,671
| – | – | 0.03% | 223 |
|
|
2023
Q4 | $941K | Hold |
2,671
| – | – | 0.03% | 234 |
|
|
2023
Q3 | $1M | Hold |
2,671
| – | – | 0.03% | 225 |
|
|
2023
Q2 | $1.02M | Hold |
2,671
| – | – | 0.03% | 221 |
|
|
2023
Q1 | $925K | Hold |
2,671
| – | – | 0.03% | 226 |
|
|
2022
Q4 | $629K | Hold |
2,671
| – | – | 0.02% | 271 |
|
|
2022
Q3 | $657K | Sell |
2,671
-20
| -0.7% | -$4.92K | 0.03% | 255 |
|
|
2022
Q2 | $814K | Buy |
2,691
+5
| +0.2% | +$1.51K | 0.03% | 242 |
|
|
2022
Q1 | $823K | Hold |
2,686
| – | – | 0.03% | 241 |
|
|
2021
Q4 | $1.26M | Hold |
2,686
| – | – | 0.04% | 211 |
|
|
2021
Q3 | $1.14M | Hold |
2,686
| – | – | 0.04% | 211 |
|
|
2021
Q2 | $965K | Hold |
2,686
| – | – | 0.04% | 230 |
|
|
2021
Q1 | $757K | Buy |
+2,686
| New | +$757K | 0.03% | 235 |
|
|
2018
Q4 | – | Sell |
-60
| Closed | -$7K | – | 1316 |
|
|
2018
Q3 | $7K | Buy |
+60
| New | +$7K | ﹤0.01% | 1147 |
|